Cargando…
Newborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy
Newborn screening for 21-hydroxylase deficiency (21OHD), the most common form of congenital adrenal hyperplasia, has been performed routinely in the United States and other countries for over 20 years. Screening provides the opportunity for early detection and treatment of patients with 21OHD, preve...
Autores principales: | Held, Patrice K., Bird, Ian M., Heather, Natasha L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569755/ https://www.ncbi.nlm.nih.gov/pubmed/33117906 http://dx.doi.org/10.3390/ijns6030067 |
Ejemplares similares
-
Wisconsin’s Screening Algorithm for the Identification of Newborns with Congenital Adrenal Hyperplasia
por: Bialk, Eric R., et al.
Publicado: (2019) -
Newborn screening for congenital adrenal hyperplasia in New York State
por: Pearce, Melissa, et al.
Publicado: (2016) -
Landscape of Congenital Adrenal Hyperplasia Newborn Screening in the United States
por: Edelman, Sari, et al.
Publicado: (2020) -
Impact of Newborn Screening on Clinical Presentation of Congenital Adrenal Hyperplasia
por: Navardauskaitė, Rūta, et al.
Publicado: (2021) -
Evaluation of a New Laboratory Protocol for Newborn Screening for Congenital Adrenal Hyperplasia in New Zealand
por: de Hora, Mark R., et al.
Publicado: (2022)